Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial

Published:2003-02 Issue:2 Volume:18 Page:152-156
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

SOLANKI PRASHANT,CHAWLA ATUL,GARG RAMESH,GUPTA RAJIV,JAIN MONIKA,SARIN SHIV K

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1746.2003.02934.x/fullpdf

Reference22 articles.

1. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites;Gines;Gastroenterology,1993

2. Hepatorenal syndrome;Gines;J. Am. Soc. Nephrol.,1999

3. Orthotopic liver transplantation and renal function: outcome of hepatorenal syndrome and trial of verapamil for renal protection in non-hepatorenal syndrome;Gonwa;Transplantation Proc.,1993

4. Effects of renal impairment on liver transplantation;Rimola;Gastroenterology,1987

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cirrhosis in the tropics;Treatment and Management of Tropical Liver Disease;2025

2. Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-09-04

3. Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis;Cureus;2024-08-16

4. Pharmacologic Treatment of Portal Hypertension;Clinics in Liver Disease;2024-08

5. Renal Complications in Portal Hypertension;Clinics in Liver Disease;2024-08